Daniel Sumpton

956 total citations
16 papers, 205 citations indexed

About

Daniel Sumpton is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Daniel Sumpton has authored 16 papers receiving a total of 205 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 5 papers in Immunology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Daniel Sumpton's work include Rheumatoid Arthritis Research and Therapies (6 papers), Psoriasis: Treatment and Pathogenesis (5 papers) and Spondyloarthritis Studies and Treatments (3 papers). Daniel Sumpton is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (6 papers), Psoriasis: Treatment and Pathogenesis (5 papers) and Spondyloarthritis Studies and Treatments (3 papers). Daniel Sumpton collaborates with scholars based in Australia, Canada and France. Daniel Sumpton's co-authors include Allison Tong, Jonathan C. Craig, Ayano Kelly, David J. Tunnicliffe, Geraldine Hassett, Vivek Thakkar, Davinder Singh‐Grewal, Kathleen Tymms, Sean O’Neill and Kieran Fallon and has published in prestigious journals such as Annals of the Rheumatic Diseases, Arthritis Care & Research and The Journal of Rheumatology.

In The Last Decade

Daniel Sumpton

13 papers receiving 202 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Sumpton Australia 9 102 51 42 34 33 16 205
C. Sheehy Ireland 6 90 0.9× 15 0.3× 19 0.5× 29 0.9× 14 0.4× 14 173
Hannah Labinsky Germany 9 119 1.2× 29 0.6× 36 0.9× 41 1.2× 8 0.2× 25 228
E Sullivan United Kingdom 13 193 1.9× 227 4.5× 23 0.5× 75 2.2× 18 0.5× 28 399
C. Zabalan Spain 2 157 1.5× 31 0.6× 19 0.5× 77 2.3× 10 0.3× 4 212
Claire Barrett Australia 9 126 1.2× 33 0.6× 27 0.6× 38 1.1× 15 0.5× 30 243
Ismail Kasujee Spain 8 47 0.5× 96 1.9× 22 0.5× 7 0.2× 16 0.5× 30 336
Annelieke Pasma Netherlands 8 201 2.0× 25 0.5× 43 1.0× 69 2.0× 78 2.4× 21 329
Maryse Mézières France 5 93 0.9× 25 0.5× 21 0.5× 42 1.2× 23 0.7× 11 158
Sheena Hennell United Kingdom 6 215 2.1× 13 0.3× 52 1.2× 114 3.4× 23 0.7× 10 290
Virginia Noxon United States 9 25 0.2× 18 0.4× 53 1.3× 21 0.6× 13 0.4× 31 163

Countries citing papers authored by Daniel Sumpton

Since Specialization
Citations

This map shows the geographic impact of Daniel Sumpton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Sumpton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Sumpton more than expected).

Fields of papers citing papers by Daniel Sumpton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Sumpton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Sumpton. The network helps show where Daniel Sumpton may publish in the future.

Co-authorship network of co-authors of Daniel Sumpton

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Sumpton. A scholar is included among the top collaborators of Daniel Sumpton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Sumpton. Daniel Sumpton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Singh‐Grewal, Davinder, et al.. (2022). Range and consistency of outcome measures reported in randomised trials in dermatomyositis: a systematic review. Clinical and Experimental Rheumatology. 40(2). 358–365.
3.
Sumpton, Daniel, Arvin Damodaran, Nicole Wong Doo, et al.. (2022). VEXAS syndrome: lessons learnt from an early Australian case series. Internal Medicine Journal. 52(4). 658–662. 31 indexed citations
4.
Sumpton, Daniel, Ayano Kelly, Jonathan C. Craig, et al.. (2021). Preferences for Biologic Treatment in Patients With Psoriatic Arthritis: A Discrete Choice Experiment. Arthritis Care & Research. 74(8). 1234–1243. 9 indexed citations
5.
Sumpton, Daniel, et al.. (2021). Patients' Perspectives on Shared Decision‐Making About Medications in Psoriatic Arthritis: An Interview Study. Arthritis Care & Research. 74(12). 2066–2075. 8 indexed citations
6.
Kelly, Ayano, Kathleen Tymms, Kieran Fallon, et al.. (2020). Qualitative Research in Rheumatology: An Overview of Methods and Contributions to Practice and Policy. The Journal of Rheumatology. 48(1). 6–15. 13 indexed citations
7.
Sumpton, Daniel, Ayano Kelly, David J. Tunnicliffe, et al.. (2020). Clinicians’ perspectives of shared care of psoriatic arthritis and psoriasis between rheumatology and dermatology: an interview study. Clinical Rheumatology. 40(4). 1369–1380. 7 indexed citations
8.
Sumpton, Daniel, Ayano Kelly, David J. Tunnicliffe, et al.. (2020). A practical guide to interpreting and applying systematic reviews of qualitative studies in rheumatology. International Journal of Rheumatic Diseases. 24(1). 28–35. 4 indexed citations
9.
Sumpton, Daniel, Ayano Kelly, David J. Tunnicliffe, et al.. (2019). Patients’ Perspectives and Experience of Psoriasis and Psoriatic Arthritis: A Systematic Review and Thematic Synthesis of Qualitative Studies. Arthritis Care & Research. 72(5). 711–722. 34 indexed citations
10.
Sumpton, Daniel, Adrien Bigot, Bénédicte Sautenet, et al.. (2019). Scope and Consistency of Outcomes Reported in Trials of Patients With Systemic Sclerosis. Arthritis Care & Research. 72(10). 1449–1458. 8 indexed citations
11.
Sumpton, Daniel, Ayano Kelly, David J. Tunnicliffe, et al.. (2018). AB1237 Patients' perspectives and experience of psoriasis and psoriatic arthritis: a systematic review and thematic synthesis of qualitative studies. Annals of the Rheumatic Diseases. 77. 1715–1715.
12.
Tunnicliffe, David J., Davinder Singh‐Grewal, Jonathan C. Craig, et al.. (2017). Perspectives of Medical Specialists From Different Disciplines on the Management of Systemic Lupus Erythematosus: An Interview Study. Arthritis Care & Research. 70(9). 1284–1293. 4 indexed citations
13.
Kelly, Ayano, Kathleen Tymms, David J. Tunnicliffe, et al.. (2017). Patients’ Attitudes and Experiences of Disease‐Modifying Antirheumatic Drugs in Rheumatoid Arthritis and Spondyloarthritis: A Qualitative Synthesis. Arthritis Care & Research. 70(4). 525–532. 35 indexed citations
14.
Sumpton, Daniel, Vivek Thakkar, Sean O’Neill, et al.. (2017). “It's Not Me, It's Not Really Me.” Insights From Patients on Living With Systemic Sclerosis: An Interview Study. Arthritis Care & Research. 69(11). 1733–1742. 33 indexed citations
15.
Tunnicliffe, David J., Davinder Singh‐Grewal, Jonathan C. Craig, et al.. (2017). 384 Multi-specialists’ perspectives on clinical decision making in systemic lupus erythematosus: an interview study. A174.3–A177. 1 indexed citations
16.
Sumpton, Daniel, et al.. (2013). Nature and Impact of Interruptions on Clinical Workflow of Medical Residents in the Inpatient Setting. Journal of Graduate Medical Education. 5(2). 232–237. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026